Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Guinan

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Urologia Internationalis|January 1, 1976
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. IV. Leucocyte adherence inhibitionR J Ablin, R A Bhatti, P D Guinan, et al.
Experientia|November 15, 1979
Effect of human seminal plasma on tumour-associated immunity in prostatic cancer. A preliminary reportR J Ablin, R A Bhatti, P D Guinan, et al.
Current Therapeutic Research, Clinical and Experimental|August 1, 1974
"Immunostaging" as a guideline to immunotherapy in malignancyR J Ablin, P D Guinan, G R Bruns, et al.
Oncology|January 1, 1974
Migration-inhibitory effect of serum from patients with prostatic cancerR J Ablin, G R Bruns, P D Guinan, et al.
Urology|December 1, 1974
Editorial: "immunostaging" patients with malignant diseaseP D Guinan, R J Ablin, G R Bruns, et al.
Urologia Internationalis|January 1, 1976
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. I. Thymic-dependent lymphocytic blastogenesisR J Ablin, G R Bruns, P D Guinan, et al.
JAMA|September 30, 1974
Letter: Diethylstilbestrol exposure and lymphocytic impairmentR J Ablin, G R Bruns, P D Guinan, et al.
European Journal of Cancer|June 1, 1980
Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasmaR J Ablin, R A Bhatti, I M Bush, et al.
American Journal of Reproductive Immunology and Microbiology : AJRIM|July 1, 1985
Effect of transfer factor on tumor-associated immunity and tumor growth of the Dunning R-3327G rat prostate adenocarcinomaM W Shaw, R J Ablin, P D Guinan, et al.
Immunopharmacology and Immunotoxicology|January 1, 1988
Effect of BCG upon functional and phenotypic immune markers in rats bearing the Dunning R3327 MAT-LyLu prostatic adenocarcinomaM Rubenstein, M W Shaw, A Dubin, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Urologia Internationalis|January 1, 1976
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. IV. Leucocyte adherence inhibitionR J Ablin, R A Bhatti, P D Guinan, et al.
Experientia|November 15, 1979
Effect of human seminal plasma on tumour-associated immunity in prostatic cancer. A preliminary reportR J Ablin, R A Bhatti, P D Guinan, et al.
Current Therapeutic Research, Clinical and Experimental|August 1, 1974
"Immunostaging" as a guideline to immunotherapy in malignancyR J Ablin, P D Guinan, G R Bruns, et al.
Oncology|January 1, 1974
Migration-inhibitory effect of serum from patients with prostatic cancerR J Ablin, G R Bruns, P D Guinan, et al.
Urology|December 1, 1974
Editorial: "immunostaging" patients with malignant diseaseP D Guinan, R J Ablin, G R Bruns, et al.
Urologia Internationalis|January 1, 1976
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. I. Thymic-dependent lymphocytic blastogenesisR J Ablin, G R Bruns, P D Guinan, et al.
JAMA|September 30, 1974
Letter: Diethylstilbestrol exposure and lymphocytic impairmentR J Ablin, G R Bruns, P D Guinan, et al.
European Journal of Cancer|June 1, 1980
Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasmaR J Ablin, R A Bhatti, I M Bush, et al.
American Journal of Reproductive Immunology and Microbiology : AJRIM|July 1, 1985
Effect of transfer factor on tumor-associated immunity and tumor growth of the Dunning R-3327G rat prostate adenocarcinomaM W Shaw, R J Ablin, P D Guinan, et al.
Immunopharmacology and Immunotoxicology|January 1, 1988
Effect of BCG upon functional and phenotypic immune markers in rats bearing the Dunning R3327 MAT-LyLu prostatic adenocarcinomaM Rubenstein, M W Shaw, A Dubin, et al.
Pageof 8